Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Cash Equivalents | 9.43 | - | - | - |
Short Term Investments | 11.34 | 13.09 | 13.92 | 15.63 |
Cashand Short Term Investments | 20.77 | 20.59 | 34.25 | 21.54 |
Accounts Receivable- Trade Net | 704.55 | 864.84 | 749.90 | 555.23 |
Total Receivables Net | 704.79 | 954.89 | 832.46 | 619.29 |
Total Inventory | 485.89 | 516.29 | 525.94 | 415.00 |
Other Current Assets Total | 109.27 | 0.58 | 0.72 | 0.97 |
Total Current Assets | 1,320.72 | 1,492.35 | 1,393.37 | 1,056.80 |
Property/ Plant/ Equipment Total- Gross | 225.23 | 1,414.33 | 1,248.65 | 1,120.02 |
Property/ Plant/ Equipment Total- Net | 1,035.14 | 885.78 | 766.52 | 684.40 |
Intangibles Net | 36.83 | 0.79 | 0.15 | 0.26 |
Long Term Investments | 19.97 | 18.80 | 19.48 | 17.30 |
Other Long Term Assets Total | 19.70 | 0.00 | 0.00 | 0.00 |
Total Assets | 2,432.36 | 2,421.40 | 2,207.96 | 1,766.01 |
Accounts Payable | 425.49 | 480.27 | 468.67 | 329.97 |
Current Portof LT Debt/ Capital Leases | 288.04 | 40.77 | 46.10 | 42.41 |
Other Currentliabilities Total | 82.01 | 42.80 | 64.21 | 64.97 |
Total Current Liabilities | 795.54 | 932.98 | 940.06 | 595.36 |
Long Term Debt | 275.33 | 204.68 | 138.50 | 147.56 |
Capital Lease Obligations | 0.91 | 0.40 | 1.88 | 3.58 |
Total Long Term Debt | 276.24 | 205.08 | 140.38 | 151.14 |
Total Debt | 564.28 | 608.91 | 542.82 | 350.76 |
Deferred Income Tax | 75.71 | 70.97 | 72.43 | 77.13 |
Minority Interest | 0.41 | 0.23 | -0.06 | -0.02 |
Other Liabilities Total | 2.91 | 19.70 | 18.79 | 28.98 |
Total Liabilities | 1,150.81 | 1,228.96 | 1,171.60 | 852.59 |
Common Stock Total | 91.94 | 92.60 | 92.60 | 93.20 |
Retained Earnings( Accumulated Deficit) | 1,189.61 | 1,090.00 | 933.92 | 811.07 |
Total Equity | 1,281.55 | 1,192.43 | 1,036.36 | 913.42 |
Total Liabilities Shareholders' Equity | 2,432.36 | 2,421.40 | 2,207.96 | 1,766.01 |
Total Common Shares Outstanding | 9.19 | 9.26 | 9.26 | 9.32 |
Tangible Book Valueper Share Common Eq | 135.39 | 128.69 | 111.90 | 97.98 |
Cash | - | 7.50 | 20.33 | 5.90 |
Accumulated Depreciation Total | - | -528.54 | -482.13 | -435.62 |
Note Receivable- Long Term | - | 23.67 | 28.44 | 7.26 |
Accrued Expenses | - | 6.07 | 4.73 | 0.80 |
Notes Payable/ Short Term Debt | - | 363.07 | 356.34 | 157.21 |
Other Equity Total | - | 9.84 | 9.84 | 9.15 |
Aarti Drugs Dividend Aarti Drugs Bonus Aarti Drugs News Aarti Drugs AGM Aarti Drugs Rights Aarti Drugs Splits Aarti Drugs Board Meetings Aarti Drugs Key Metrics Aarti Drugs Shareholdings Aarti Drugs Profit Loss Aarti Drugs Cashflow Aarti Drugs Q1 Results Aarti Drugs Q2 Results Aarti Drugs Q3 Results Aarti Drugs Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks